000 | 02144nam a22002537a 4500 | ||
---|---|---|---|
999 |
_c8287 _d8287 |
||
001 | ANES 2015 0002 | ||
003 | PILC | ||
005 | 20240720152624.0 | ||
008 | 160505b2015 xxu||||| |||| 00| 0 eng d | ||
040 |
_beng _cFEU-NRMF MEDICAL LIBRARY _erda |
||
041 | _aenglish | ||
050 | _aANES 2015 0002 | ||
245 |
_aEfficacy of intravenous paracetamol as preemptive analgesia in patients who underwent laparoscopic cholecystectomy / _cCharlene Rose P. Syjuco. |
||
260 |
_aFairview, Quezon City: _bDepartment of Anesthesiology, FEU-NRMF, _c2015. |
||
300 |
_a33 pages: _billustrations, tables; _c(in folder) |
||
336 |
_atext _2rdacontent |
||
337 |
_aunmediated _2rdamedia |
||
338 |
_avolume _2rdacarrier |
||
504 | _aIncludes appendices and bibliographical references. | ||
520 | _aAbstract: Pain is the most common complaint of patients who underwent laparoscopic cholecystectomy requiring 80% of patients to receive opioid rescue dose. The objective of this study was to determine the efficacy of preemptive IV paracetamol in patients undergoing laparoscopic cholecystectomy. Sixty ASA (American Society of Anesthesiologist) 1 and 2 patients (> 18 years old) were included in this randomized, double-blind, controlled study, Group 1 receive IV paracetamol (1g) and group 2 received placebo, both one hour prior to procedure. Total number of top up of Fentanyl (25ug) intraoperatively and total number of rescue medication of Nalbuphine (5mg) postoperatively were the parameters assessed and compared in this study. Intensity of pain was assessed using the Visual analog scale(V A S) at different postoperative times ( 1h, 6h, 12h, 18h and 24h). The IV paracetamol group showed lower consumption of opioid intraoperatively (p<0.05) and postoperatively (p<0.05) than the placebo group. The IV Paracetamol group also showed lower pain intensity (p<0.05) than the placebo group at different time interval ( 1h, 6h and 12h). Preemptive IV paracetamol is an effective preemptive analgesic in patients who underwent laparoscopic cholecystectomy. | ||
521 | _aRESDA | ||
700 |
_aSyjuco, Charlene Rose P., MD. _eauthor |
||
942 |
_2lcc _cRU |